CLINICAL_TRIALS
trial_result
· 2023-04-07
Clinical Trial Update: A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain [NA]
Summary
Phase IV post-approval study of ExAblate for palliation of pain in metastatic bone tumors has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: InSightec | Conditions: Bone Metastasis | NA | Status: COMPLETED | Results posted: 2023-04-07